NCT00491504View on ClinicalTrials.gov

This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)

PHASE4CompletedINTERVENTIONAL

Enrollment

310

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Mometasone Furoate Nasal Spray

Mometasone Furoate Nasal Spray: 2 sprays (50 mcg) each nostril (total 200 mcg)

OTHER

Placebo

Placebo: 2 sprays in each nostril

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00491504 - This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED) | Biotech Hunter | Biotech Hunter